Vivexia

Vivexia is a private French contract research organization focused on preclinical evaluation of anti-infective therapies. The company develops humanized and non-humanized in vivo infection models and provides in vitro microbiology services to support screening, proof-of-concept, pharmacokinetic/pharmacodynamic characterization, and non-GLP preclinical testing. Its work is centered on antimicrobial resistance, biofilm-related infections, and other difficult infectious disease settings relevant to drug developers and healthcare institutions. Vivexia supports a range of anti-infective modalities, including small molecules, peptides, biologics, vaccines, natural products, and bacteriophages. The company also offers susceptibility, resistance, antibiofilm, PK/bioanalysis, and histopathology services, and collaborates closely with infectious disease groups in Dijon.